Weijie Chen, Sanyuan HuDepartment of General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong Province, People's Republic of ChinaBackground: Particulate carriers are necessary to control the release of endostar and prolong its circulation in vivo. The purpose of this study was to identify a suitable carrier for the capsulation and delivery of endostar.Methods: We prepared a series of poly (DL-lactide-co-glycolide) (PLGA) and poly (ethylene glycol) (PEG)-modified PLGA (PEG-PLGA) particulate carriers, and then characterized them according to their ability to prolong the circulation of endostar, their physicochemical properties, endostar-loading content, and in vitro and in vivo particulate carrier release profiles.Resul...
Poly(D,L-lactic-co-glycolic acid) (PLGA)/poly (lactic acid) (PLA) microspheres/nanoparticles are one...
Drug delivery systems (DDS) based on poly (lactide-co-glycolide) (PLGA) microspheres and nanospheres...
The therapeutic potential of a number of active substances can not be realized in clinical practice ...
Sanyuan Hu1, Yangde Zhang21Xiangya School of Medicine and 2National Hepatobiliary and Enteric Surger...
Poly(lactide-co-glycolide) [PLGA] is the most exploited biodegradable and biocompatible material in ...
Poly(lactic-co-glycolic acid) (PLGA) microspheres have been widely used as drug carriers for minimal...
Microcapsules have been widely studied owing to their biocompatibility and potential for application...
Poly(lactic-co-glycolic acid) (PLGA) microspheres have been widely used for minimally invasive, loca...
Injectable blood persistent particulate carriers have important therapeutic application in site-spec...
Over the previous years, the design, development, and potential application of nanocarriers in the m...
Modern endometritis therapeutics may require an extremely precise and controlled drug release system...
The purpose of this study was to develop different injectable nanosized drug delivery systems (NDDSs...
Shaoping Sun,1 Na Liang,2 Hiromitsu Yamamoto,3 Yoshiaki Kawashima,3 Fude Cui,4 Pengfei Yan1,5 1Key ...
Clinical studies have demonstrated the efficacy of new strategies in cancer therapy, such as chemoth...
Jianwei Duan,1,* Chao Liu,1,* Xiaoyu Liang,1 Xuanling Li,1 Youlu Chen,1 Zuoguan Chen,2 Xiaoli Wang,1...
Poly(D,L-lactic-co-glycolic acid) (PLGA)/poly (lactic acid) (PLA) microspheres/nanoparticles are one...
Drug delivery systems (DDS) based on poly (lactide-co-glycolide) (PLGA) microspheres and nanospheres...
The therapeutic potential of a number of active substances can not be realized in clinical practice ...
Sanyuan Hu1, Yangde Zhang21Xiangya School of Medicine and 2National Hepatobiliary and Enteric Surger...
Poly(lactide-co-glycolide) [PLGA] is the most exploited biodegradable and biocompatible material in ...
Poly(lactic-co-glycolic acid) (PLGA) microspheres have been widely used as drug carriers for minimal...
Microcapsules have been widely studied owing to their biocompatibility and potential for application...
Poly(lactic-co-glycolic acid) (PLGA) microspheres have been widely used for minimally invasive, loca...
Injectable blood persistent particulate carriers have important therapeutic application in site-spec...
Over the previous years, the design, development, and potential application of nanocarriers in the m...
Modern endometritis therapeutics may require an extremely precise and controlled drug release system...
The purpose of this study was to develop different injectable nanosized drug delivery systems (NDDSs...
Shaoping Sun,1 Na Liang,2 Hiromitsu Yamamoto,3 Yoshiaki Kawashima,3 Fude Cui,4 Pengfei Yan1,5 1Key ...
Clinical studies have demonstrated the efficacy of new strategies in cancer therapy, such as chemoth...
Jianwei Duan,1,* Chao Liu,1,* Xiaoyu Liang,1 Xuanling Li,1 Youlu Chen,1 Zuoguan Chen,2 Xiaoli Wang,1...
Poly(D,L-lactic-co-glycolic acid) (PLGA)/poly (lactic acid) (PLA) microspheres/nanoparticles are one...
Drug delivery systems (DDS) based on poly (lactide-co-glycolide) (PLGA) microspheres and nanospheres...
The therapeutic potential of a number of active substances can not be realized in clinical practice ...